Holen Sie sich die Stockscreener-App
34.44
2.96%
-1.07
Schlusskurs vom Vortag:
$35.51
Offen:
$35.12
24-Stunden-Volumen:
285.01K
Relative Volume:
0.21
Marktkapitalisierung:
$1.75B
Einnahmen:
$2.82B
Nettoeinkommen (Verlust:
$-1.87B
KGV:
-1.2344
EPS:
-27.9
Netto-Cashflow:
$-96.80M
1W Leistung:
+33.31%
1M Leistung:
+26.32%
6M Leistung:
-11.55%
1J Leistung:
-22.00%
1-Tages-Spanne:
$34.16
$35.45
1-Wochen-Bereich:
$28.54
$38.99
52-Wochen-Spanne:
$23.77
$49.45
Quidelortho Corporation Stock (QDEL) Company Profile
Firmenname
Quidelortho Corporation
Sektor
Branche
Telefon
(858) 552-1100
Adresse
9975 SUMMERS RIDGE ROAD, SAN DIEGO, CA
Vergleichen Sie QDEL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
QDEL
Quidelortho Corporation
|
34.48 | 1.75B | 2.82B | -1.87B | -96.80M | -27.90 |
|
ABT
Abbott Laboratories
|
128.99 | 231.50B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.84 | 154.04B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
385.96 | 144.27B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
84.44 | 105.58B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
76.77 | 43.95B | 5.54B | 4.18B | 623.10M | 7.00 |
Quidelortho Corporation Stock (QDEL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-08 | Hochstufung | Jefferies | Hold → Buy |
| 2024-12-11 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-12-10 | Eingeleitet | Jefferies | Hold |
| 2024-09-19 | Fortgesetzt | UBS | Neutral |
| 2024-09-05 | Hochstufung | Craig Hallum | Hold → Buy |
| 2024-03-04 | Herabstufung | UBS | Neutral → Sell |
| 2024-02-14 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2023-12-11 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-12-12 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-10-14 | Hochstufung | UBS | Sell → Neutral |
| 2022-09-19 | Eingeleitet | Citigroup | Neutral |
| 2022-07-20 | Eingeleitet | UBS | Sell |
| 2022-06-17 | Fortgesetzt | JP Morgan | Neutral |
| 2022-02-22 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2021-01-22 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-05-12 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2020-03-26 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2018-10-23 | Fortgesetzt | Raymond James | Strong Buy |
| 2018-03-08 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2018-01-22 | Bestätigt | Barclays | Overweight |
| 2018-01-04 | Hochstufung | CL King | Neutral → Buy |
| 2017-09-19 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2017-07-18 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2017-07-18 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2017-04-25 | Bestätigt | Canaccord Genuity | Hold |
| 2017-02-17 | Eingeleitet | CL King | Neutral |
| 2016-12-16 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2016-06-13 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2016-02-18 | Bestätigt | Barclays | Overweight |
| 2016-02-09 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2016-01-08 | Bestätigt | Canaccord Genuity | Buy |
| 2015-12-14 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2015-09-02 | Eingeleitet | Barclays | Overweight |
| 2013-07-31 | Bestätigt | Canaccord Genuity | Buy |
| 2011-03-03 | Herabstufung | Wedbush | Outperform → Neutral |
Alle ansehen
Quidelortho Corporation Aktie (QDEL) Neueste Nachrichten
QuidelOrtho Corporation (NASDAQ:QDEL) Surges 32% Yet Its Low P/S Is No Reason For Excitement - simplywall.st
QuidelOrtho (QDEL) Faces Tariff Impact, Maintains 2025 Outlook - GuruFocus
Thermo Fisher, Biogen, Gilead Sciences, Moderna, and QuidelOrtho Stocks Trade Up, What You Need To Know - MSN
QuidelOrtho: Stagnant Growth Means Best To Avoid (Rating Downgrade) (NASDAQ:QDEL) - Seeking Alpha
Quidelortho sees $30M-$40M tariff impact offset, maintains 2025 guidance - MSN
QuidelOrtho Stock Gains Following Q1 Earnings Beat, Margins Expand - MSN
QuidelOrtho First Quarter 2025 Earnings: EPS Beats Expectations - simplywall.st
Jefferies upgrades QuidelOrtho to Buy, says ‘no news is good news’ - TipRanks
Why QuidelOrtho Corporation (QDEL) Went Up On Thursday - Yahoo Finance
10 Unexpected Market Movers – What Propelled Double-Digit Gains? - Insider Monkey
QuidelOrtho Earnings Call: Growth Amid Challenges - TipRanks
Jefferies Upgrades QuidelOrtho (QDEL) - Nasdaq
QuidelOrtho Corporation f/k/a Quidel Corporation Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky for More InformationQDEL - ACCESS Newswire
UBS Maintains Neutral Rating for QuidelOrtho (QDEL), Lowers Price Target | QDEL Stock News - GuruFocus
Why Is QuidelOrtho (QDEL) Stock Soaring Today - Yahoo Finance
Global Immunodiagnostics Market to Cross the USD 32 Billion by 2032 | DelveInsight - GlobeNewswire Inc.
QuidelOrtho (QDEL) Upgraded to Buy by Jefferies | QDEL Stock News - GuruFocus
QuidelOrtho Shares Gain After Q1 Adjusted Earnings Beat Consensus - marketscreener.com
Jefferies Elevates QuidelOrtho (QDEL) to Buy Rating Amid Positiv - GuruFocus
UBS Reduces Price Target for QuidelOrtho (QDEL) to $29 | QDEL Stock News - GuruFocus
UBS Cuts Price Target on QuidelOrtho to $29 From $45, Keeps Neutral Rating - marketscreener.com
QuidelOrtho Corporation (NASDAQ:QDEL) Q1 2025 Earnings Call Transcript - Insider Monkey
QuidelOrtho revenue increases 5% to USD 693M in Q1 2025 - Medical Buyer
QuidelOrtho's Q1 CY2025 Financial Performance: Revenue Decline and Profit GrowthNews and Statistics - IndexBox
QuidelOrtho Q1 Adjusted Earnings Rise, Revenue Falls; Fiscal 2025 Guidance Maintained - marketscreener.com
QuidelOrtho Corp (QDEL) Q1 2025 Earnings Call Highlights: Strong Growth in Core Segments Amid ... - Yahoo Finance
QuidelOrtho Corp (QDEL) Q1 2025 Earnings Call Highlights: Strong Growth in Core Segments Amid Revenue Decline - GuruFocus
QuidelOrtho: Q1 Earnings Snapshot - Norwalk Hour
QuidelOrtho Q1 2025 presentation slides: EPS surges 68% despite flat revenue By Investing.com - Investing.com South Africa
QuidelOrtho Reports Strong Q1 2025 Financial Results - TipRanks
QuidelOrtho Corp reports results for the quarter ended March 31Earnings Summary - TradingView
Earnings call transcript: QuidelOrtho Q1 2025 beats EPS, stock up 7.5% - Investing.com Australia
QuidelOrtho Q1 2025 presentation slides: EPS surges 68% despite flat revenue - Investing.com
QDEL Confident in Minimizing Tariff Impacts | QDEL Stock News - GuruFocus
QuidelOrtho (QDEL) Q1 Earnings and Revenues Top Estimates - Yahoo Finance
QuidelOrtho (NASDAQ:QDEL) Reports Q1 In Line With Expectations, Stock Soars - Yahoo Finance
QuidelOrtho (NASDAQ:QDEL) Reports Q1 In Line With Expectations - FinancialContent
QuidelOrtho sees FY25 Labs business growth in mid-single digits - TipRanks
Quidel shares surge 7.8% as Q1 earnings beat estimates By Investing.com - Investing.com Nigeria
QuidelOrtho (QDEL) Projects Steady Growth Across Key Segments for 2025 | QDEL Stock News - GuruFocus
Quidel shares surge 7.8% as Q1 earnings beat estimates - Investing.com Australia
QuidelOrtho (QDEL) Exceeds Q1 Revenue Expectations | QDEL Stock News - GuruFocus
QuidelOrtho Corp Q1 2025 Earnings: Adjusted EPS of $0.74 Beats Estimates, Revenue Hits $693 Million Surpassing Projections - GuruFocus
(QDEL) QUIDELORTHO CORPORATION Sees Q2 Adjusted EPS Range $2.07$2.57 - marketscreener.com
QuidelOrtho Reports First Quarter 2025 Financial Results - Stock Titan
QuidelOrtho (QDEL) Earnings Expected to Grow: Should You Buy? - MSN
MedTech Stocks' Earnings to Watch on May 7: COR, QDEL & INGN - TradingView
QuidelOrtho Earnings: What To Look For From QDEL - Yahoo Finance
Class Action Filed Against QuidelOrtho Corporation f/k/a Quidel Corporation (QDEL)June 11, 2024 Deadline to JoinContact Levi & Korsinsky - ACCESS Newswire
Lost Money on QuidelOrtho Corporation f/k/a Quidel Corporation (QDEL)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky - ACCESS Newswire
Levi & Korsinsky Reminds QuidelOrtho Corporation f/k/a Quidel Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 11, 2024QDEL - ACCESS Newswire
Finanzdaten der Quidelortho Corporation-Aktie (QDEL)
Umsatz
Nettogewinn
Free Cashflow
ENV
Quidelortho Corporation-Aktie (QDEL) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Blaser Brian J. | President and CEO |
Dec 11 '24 |
Buy |
41.42 |
6,033 |
249,878 |
6,033 |
2.18%
2.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):